Advertisement

Topics

Advertisement

Solid Tumors

Hematologic Malignancies

Issues in Oncology

Supportive Care

Advertisement

Advertisement



Feb
24
Today In Oncology
Talazoparib for Pretreated Patients With Metastatic Castration-Resistant Prostate Cancer
HSD3B1 Genotype and Its Effect on Castration Resistance and Overall Survival in Prostate Cancer
IASLC Early Lung Imaging Confederation Initiative for Analysis of Low-Dose CT Images
Osimertinib Plus Savolitinib for EGFR-Mutated, MET-Amplified NSCLC After Progression on EGFR Tyrosine Kinase Inhibitors
PROs With Addition of Pembrolizumab vs Placebo to Pemetrexed and Platinum for Nonsquamous NSCLC
View More 
Advertisement
Most Read Stories
How I Work up the Patient with Thrombocytosis
2020 GU Cancers Symposium: Talazoparib for Pretreated Patients With Metastatic Castration-Resistant Prostate Cancer
Dengue Virus Infection May Increase Risk of Developing Leukemia
2020 GU Cancers Symposium: Enfortumab Vedotin Plus Pembrolizumab in Bladder Cancer
Management of HER2-Positive Breast Cancer: Business as Usual?
View More 
Most Viewed Videos
Ziad Bakouny, MD, on Metastatic Kidney Cancer: Defining the Role of Cytoreductive Nephrectomy
Jonathan E. Rosenberg, MD, on Locally Advanced or Metastatic Urothelial Carcinoma: Enfortumab Vedotin Plus Pembrolizumab
Francesca Battaglin, MD, on Colorectal Cancer: Using Genetic Variants to Predict Treatment Efficacy
Nizar M. Tannir, MD, on Nivolumab/Ipilimumab vs Sunitinib in Advanced Kidney Cancer
Syed A. Hussain, MD, on Muscle-Invasive Bladder Cancer: NEO-BLADE Trial of Nintedanib Plus Chemotherapy
View More 
© 2020 HSP News Service, L.L.C.